Merck KGaA injecting €150M into biologics site where it makes immunotherapies

Merck KGaA injecting €150M into biologics site where it makes immunotherapies

Submitted by admin on March 28, 2019 - 8:00pm
Source: 
Fierce Pharma
News Tags: 
Merck KGaA
Switzerland
drug manufacturing
biologics
Headline: 
Merck KGaA injecting €150M into biologics site where it makes immunotherapies
snippet: 

Just a week after promising a €1 billion investment in its headquarters manufacturing site in Germany, Merck KGaA says it will also invest €150 million into its biologics site in Switzerland.

Do Not Allow Advertisers to Use My Personal information